Neuraxis
Price & Volume
Stats
See more52W Range | $2.07-$9.33 |
Market Cap | $94.3M |
Shares Short | 263,600 |
Financials
See moreRevenue (12 Mos) | $3.5M |
Revenue Growth (YoY) | 27.2% |
Gross Profit (12 Mos) | $3M |
Diluted EPS | -$0.95 |
News
See moreYahoo Finance • 7 days ago
NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026
Yahoo Finance • last month
NeurAxis, Inc. Announces Preferred Stock Dividend
Yahoo Finance • 7 months ago
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
Yahoo Finance • 9 months ago
NeurAxis reports Q2 results
About
CEO | Mr. Brian Carrico |
Address | 11611 North Meridian St, Carmel, IN, United States, 46032 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 24 |